Co-Diagnostics (CODX) Competitors $0.25 0.00 (-1.91%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$0.25 +0.00 (+1.34%) As of 08:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CODX vs. COCH, VVOS, CLGN, FEMY, DRIO, PETV, RVP, IRIX, ALUR, and NXGLShould you be buying Co-Diagnostics stock or one of its competitors? The main competitors of Co-Diagnostics include Envoy Medical (COCH), Vivos Therapeutics (VVOS), CollPlant Biotechnologies (CLGN), Femasys (FEMY), DarioHealth (DRIO), PetVivo (PETV), Retractable Technologies (RVP), IRIDEX (IRIX), Allurion Technologies (ALUR), and NexGel (NXGL). These companies are all part of the "medical equipment" industry. Co-Diagnostics vs. Its Competitors Envoy Medical Vivos Therapeutics CollPlant Biotechnologies Femasys DarioHealth PetVivo Retractable Technologies IRIDEX Allurion Technologies NexGel Co-Diagnostics (NASDAQ:CODX) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership. Is CODX or COCH more profitable? Co-Diagnostics has a net margin of -1,025.45% compared to Envoy Medical's net margin of -10,961.26%. Envoy Medical's return on equity of 0.00% beat Co-Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Co-Diagnostics-1,025.45% -60.16% -52.69% Envoy Medical -10,961.26%N/A -236.14% Which has more risk & volatility, CODX or COCH? Co-Diagnostics has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.21, suggesting that its share price is 121% more volatile than the S&P 500. Do analysts rate CODX or COCH? Co-Diagnostics currently has a consensus target price of $5.50, suggesting a potential upside of 2,129.43%. Envoy Medical has a consensus target price of $9.25, suggesting a potential upside of 529.25%. Given Co-Diagnostics' higher probable upside, equities research analysts clearly believe Co-Diagnostics is more favorable than Envoy Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Co-Diagnostics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, CODX or COCH? Envoy Medical has lower revenue, but higher earnings than Co-Diagnostics. Envoy Medical is trading at a lower price-to-earnings ratio than Co-Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCo-Diagnostics$3.91M2.12-$37.64M-$1.17-0.21Envoy Medical$220K142.52-$20.80M-$1.43-1.03 Does the media refer more to CODX or COCH? In the previous week, Co-Diagnostics had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Co-Diagnostics and 1 mentions for Envoy Medical. Co-Diagnostics' average media sentiment score of -0.33 beat Envoy Medical's score of -1.00 indicating that Co-Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Co-Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Do insiders & institutionals hold more shares of CODX or COCH? 15.0% of Co-Diagnostics shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 8.4% of Co-Diagnostics shares are held by insiders. Comparatively, 58.9% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryCo-Diagnostics beats Envoy Medical on 10 of the 16 factors compared between the two stocks. Get Co-Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CODX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CODX vs. The Competition Export to ExcelMetricCo-DiagnosticsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.44M$7.13B$5.42B$9.56BDividend YieldN/A2.83%3.99%4.14%P/E Ratio-0.2162.8629.9025.14Price / Sales2.1226.91372.1776.15Price / CashN/A26.5935.9458.58Price / Book0.1517.548.105.59Net Income-$37.64M$239.96M$3.26B$265.48M7 Day Performance-0.60%1.08%0.65%1.22%1 Month Performance-11.96%-3.72%2.43%0.39%1 Year Performance-75.81%22.84%27.70%23.47% Co-Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CODXCo-Diagnostics3.9697 of 5 stars$0.25-1.9%$5.50+2,129.4%-76.9%$8.44M$3.91M-0.21100News CoverageUpcoming EarningsCOCHEnvoy Medical1.981 of 5 stars$1.43-1.0%$9.25+546.9%-35.8%$30.82M$220K-1.0034Negative NewsUpcoming EarningsVVOSVivos Therapeutics0.4357 of 5 stars$4.76-8.1%$4.82+1.2%+120.5%$30.51M$15.03M-2.75160Upcoming EarningsCLGNCollPlant Biotechnologies1.5431 of 5 stars$2.25-1.7%$11.50+411.1%-36.8%$29.13M$510K-1.8470FEMYFemasys2.8203 of 5 stars$0.81-1.4%$8.67+972.2%-16.0%$26.66M$1.70M-0.8930Upcoming EarningsDRIODarioHealth1.4477 of 5 stars$0.55+0.0%$2.00+263.6%-43.4%$25.03M$27.04M-0.98200Upcoming EarningsPETVPetVivoN/A$0.80-1.0%N/A+55.6%$22.00M$1.05M-1.7820News CoverageUpcoming EarningsGap UpRVPRetractable Technologies2.8989 of 5 stars$0.73-1.7%N/A-26.8%$21.86M$33.75M-1.35240Positive NewsIRIXIRIDEX0.3484 of 5 stars$1.32+3.1%N/A-30.8%$21.49M$48.67M-3.07120Upcoming EarningsGap UpALURAllurion Technologies1.9899 of 5 stars$2.85+2.9%$22.83+701.2%-85.2%$20.62M$32.11M-0.23501Upcoming EarningsNXGLNexGel0.5328 of 5 stars$2.60+1.2%N/A-5.4%$19.67M$8.69M-5.7810News CoveragePositive News Related Companies and Tools Related Companies COCH Competitors VVOS Competitors CLGN Competitors FEMY Competitors DRIO Competitors PETV Competitors RVP Competitors IRIX Competitors ALUR Competitors NXGL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CODX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Co-Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Co-Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CODX Stock Alerts